Lindsay Shea is director of the Policy and Analytics Center at the A.J. Drexel Autism Institute at Drexel University in Philadelphia, Pennsylvania. She is also interim leader of the institute’s Life Course Outcomes Research Program. She focuses on research that is conducted in partnership with and that directly impacts communities and policymakers.
Lindsay Shea
Director, Policy and Analytics Center
A.J. Drexel Autism Institute
From this contributor
Pitfalls in using autism claims data: Q&A with Lindsay Shea
Insurance claims data are useful for autism research, but the field needs to standardize how they are mined, Shea says.
Pitfalls in using autism claims data: Q&A with Lindsay Shea
By
Anna Goshua
14 December 2021 | 6 min read
Explore more from The Transmitter
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
By
Claudia López Lloreda
2 October 2025 | 6 min read
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
By
Calli McMurray
2 October 2025 | 10 min read
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
By
Brendan Borrell
1 October 2025 | 11 min read